IFNG and COVID-19: Notably, individual therapeutic treatment of infected aged Ifnar1−/− mice, a model combining two of the most detrimental risk factors for severe COVID-19 in humans (O'Driscoll et al., 2021; Bastard et al., 2021), with either IFN-γ or IFN-λ had limited success in preventing severe disease and lethality.